Swertia japonica

Swertia japonica · Accepted scientific name

Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆

Swertia japonica is a medicinal plant known for its diverse therapeutic potential, particularly through its bioactive roots. Research has identified key chemical constituents such as bellidifolin, swertiamarin, thysanolactone, and various triterpenoids within its structure. When prepared as a methanol extract, powder, or ethyl acetate soluble fraction, the plant demonstrates significant hypoglycemic activities. These preparations are studied for their ability to manage hyperglycemia and influence physiological conditions like gastrointestinal motility and gastric emptying. Additionally, the plant's chemical profile plays a role in addressing anticholinergic-related conditions.

Quick facts
Synonyms
Swertia Japonica F. Chionantha · Swertia Japonica Var. Littoralis · 6 more
Common names
Not available
Family
Gentianaceae
Distribution
Africa
Plant Parts
Root

Classification

Common Names

Swertia japonica is a distinctive plant known by several different names across various linguistic traditions. In common usage, it is frequently referred to as japonska svercija or senburi. Depending on the region, you may also encounter it called sseunpul. The species holds significant cultural importance in Japan, where it is written as センブリ in Katakana. Furthermore, it is traditionally documented using the Kanji characters 千振 to denote its identity.

Sources: Catalogue of Life (COL)

Synonyms

Swertia japonica is a botanical subject characterized by a complex web of taxonomic synonyms. Scientific literature frequently refers to this species as Frasera japonica or Gentiana japonica. It is also documented under the name Ophelia japonica, which includes the specific form Ophelia japonica f. littoralis. Furthermore, certain variations are categorized as Swertia japonica f. chionantha. Understanding these overlapping designations is essential for accurate botanical identification and research.

Sources: The World Checklist of Vascular Plants (WCVP)

Taxonomy

Swertia japonica is a fascinating botanical specimen belonging to the kingdom Plantae. Within this vast biological realm, the plant is classified under the class Equisetopsida. It further falls into the order Gentianales, showcasing its specific evolutionary lineage. As a member of the genus Swertia, it shares distinct characteristics with its closely related relatives. Ultimately, this species is most recognized as a prominent representative of the family Gentianaceae.

Rank Classification
Kingdom Plantae
Phylum Streptophyta
Class Equisetopsida
Subclass Magnoliidae
Order Gentianales
Family Gentianaceae
Genus Swertia

Sources: The World Checklist of Vascular Plants (WCVP)

Distribution

Geographic Regions

Swertia japonica is a distinctive plant species primarily found throughout the temperate regions of Asia. Its natural distribution is concentrated within Eastern Asia, where it thrives in specific ecological niches. Specifically, this plant can be frequently identified growing across the diverse landscapes of Japan. It also maintains a significant presence within the temperate environments of Korea. These geographical patterns highlight the plant's specialized habitat preferences within the eastern part of the continent.

Sources: The World Checklist of Vascular Plants (WCVP)

Identification

Morphology

Swertia japonica is characterized by its distinct growth form as an herb.

Sources: Global Inventory of Floras and Traits (GIFT)

Biological Activities

Swertia japonica has demonstrated significant medicinal potential through its notable hypoglycemic activity. Research into the plant has identified bellidifolin as a particularly potent agent capable of reducing blood sugar levels in diabetic models. By utilizing activity-guided fractionation, scientists isolated several xanthones and triterpenoids, including the newly discovered thysanolactone. Studies conducted on streptozotocin-induced diabetic rats showed that bellidifolin exhibits a potent, dose-dependent effect when administered both intraperitoneally and orally. These findings highlight the plant's chemical complexity and its promise for developing new diabetes treatments.

Compounds

Swertia japonica is a medicinal plant from the Gentianaceae family that serves as a rich source of various bioactive compounds. Research has identified several key constituents within the plant, including the secoiridoid glycosides swertiamarin and sweroside. Additionally, the plant contains the xanthone bellidifolin, which has demonstrated potent hypoglycemic properties in studies. Other significant compounds isolated from its extracts include the triterpenoid thysanolactone. Together, these diverse chemical components contribute to the plant's traditional uses as a digestive and appetite stimulant.

Conditions

Swertia japonica possesses diverse medicinal properties, including the ability to treat STZ-induced diabetic rats through its hypoglycemic agent, bellidifolin. This plant also functions to treat elevated blood triglyceride levels by significantly lowering them in subjects. Its chemical constituents, such as swertiamarin, provide an effective anticholinergic action. Additionally, the plant is traditionally utilized as a digestive stimulant to aid gastrointestinal health. Finally, Swertia japonica serves as an appetite stimulant in various medicinal applications.

Preparations

Swertia japonica is prepared as an ethyl acetate soluble fraction to isolate xanthones and triterpenoids such as bellidifolin and thysanolactone. The plant is also prepared as a methanol extract, which has been shown to possess effective anticholinergic actions through its constituent swertiamarin. Additionally, Swertia japonica is prepared as a powder to study its effects on gastrointestinal motility. These various preparation methods allow for the investigation of the plant's diverse pharmacological properties, including hypoglycemic and antispasmodic activities. Each form of the plant serves a specific purpose in identifying its active bioactive compounds.

Parts used

Swertia japonica is a medicinal plant within a genus that has been utilized in traditional medicine across Asia for thousands of years. To better understand its therapeutic potential, researchers conducted a deep-transcriptome sequencing study focusing on both the aerial tissues and the roots. By analyzing these specific plant parts, the study successfully assembled a de novo transcriptome consisting of over 81,000 unigenes. This detailed investigation allowed scientists to identify putative genes responsible for the biosynthesis of key bioactive metabolites. Ultimately, comparing the metabolic processes in the aerial tissues to those in the roots provides a valuable resource for future pharmacological research.